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Abstract
Background: Cases of cytomegalovirus colitis are exceptionally reported in immuno-competent infant. The
pathogenesis is uncertain but breast-feeding is considered as a main source of postnatal infection.
Case Presentation: Here we report a full-term, formula-fed infant who developed a severe cytomegalovirus
anaemia and colitis when aged 2 months.
Conclusion: Even if the molecular identity between the cytomegalovirus-isolate of the infant and the maternal
virus could not be demonstrated, we confirmed through laboratory investigation that cytomegalovirus infection
was acquired postnatally. However, the source of cytomegalovirus infection remained unclear. Alternative modes of
cytomegalovirus transmission are discussed.
Background
Cytomegalovirus (CMV) is a ubiquitous agent that deter-
mines a wide spectrum of diseases in children and adult-
hood. Severe cytomegalovirus infection is often reported
when disease is congenital [1], acquired in premature
infants [2] or in immuno-compromised patients.
Cases of CMV gastrointestinal disease have been
exceptionally observed in immuno-competent infants.
Congenital origin could not be ruled out in all reported
c a s e s .I n f a n t sw e r eb r e a s tf e da n dm o s to ft h e mp r e -
sented CMV-disease between 5 to 8 weeks after birth,
with severe diarrhoea and fever. Possibly, the CMV trans-
mission occurred at birth or soon after, as the incubation
period of CMV infection generally ranges between 4 and
12 weeks.
Risk factors and pathogenesis of CMV gastrointestinal
disease which affects term infants during the first months
of life are poorly defined.
Case Presentation
A Chinese male infant was delivered at term by emergency
caesarean section because of foetal distress. The mother
was at first pregnancy and presented with membrane
rupture 24 hours before delivery. Maternal CMV primary
infection was diagnosed at the 27
th week of gestation
(negative serum specific CMV IgG in early pregnancy.
Positive serum specific CMV IgM at 27
th weeks of gesta-
tion. Positive CMV IgG antibodies 2 weeks later).
Family pedigree was negative for atopy, immuno-defi-
ciencies and gastrointestinal diseases. Birth weight was
3255 g, cranial circumference 34 cm and length 51 cm;
APGAR score was 9 and 10 at the 1
st and 5
th minute
respectively. An urine polymerase chain reaction (P.C.R.)
was CMV negative at birth.
Fourteen hours after birth the newborn presented with
a severe abdominal distension and breast feeding was
soon and permanently discontinued. When 2 days old
the newborn was referred to our neonatal intensive care
unit because of acute intestinal occlusion and ileum-cecal
valve atresia. Two consecutive urine shell vial assays,
obtained after admission, were CMV early antigen nega-
tive as like as specific serum CMV-IgM antibodies. In the
4
th day of life the baby underwent intestinal resection.
No blood products were administered and no inclusion
bodies were found in the intestinal biopsy. Three weeks
later the baby was discharged home; he was formula-fed
and healthy appearing.
When aged 10 weeks the infant showed fever, irritabil-
ity and decreased milk intake. Physical examination
revealed a lethargic infant, pale-greyish skin, marbled
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Blood analysis showed: white blood cell count 7.63 per
10
9/L (31% neutrophils; 61% lymphocytes; 7% mono-
cytes), haemoglobin 6.8 g/dl, hematocrit 21%, platelet
count 181 per 10
9/L, aspartate-aminotransferase 62 U/L,
alanine-aminotransferase 39 U/L, albumin 1.8 g/dl, with
normal clotting time test. Serum specific CMV immu-
noglobulin levels (IgG and IgM) were consistent with a
primary infection.
The infant showed a clinical improvement by therapy
(intravenous fluids, broad spectrum antibiotics, albumin
and packed erythrocytes), but 6 days after admission he
presented a severe haemorrhagic diarrhoea. No parasites
were found by stool examination and Rotavirus/Adeno-
virus chromatographic immunoassay was negative. Stool
cultures for Salmonella, Shigella, Campylobacter and
Yersinia species were also negative.
Al a r g ei n t e s t i n eb i o p s ys h o w e dac h r o n i ci n f l a m m a -
tion with lymphatic hyperplasia and colic crypt lesions.
Urine shell vial assay was CMV early antigen positive.
P.C.R. was positive in the biopsy (quantitative CMV-
DNA 2620 copies/100.00cells), in bone marrow (quanti-
tative CMV-DNA 2275 copies/ml) and in peripheral
blood (determined 7 days after start of antiviral therapy:
quantitative CMV-DNA 240 copies/ml).
Brain ultrasound scans, cranial computed tomography,
ophthalmologic examination and auditory brainstem
responses were normal.
Intravenous ganciclovir (GCV) (10 mg/kg/day) was
administered for 3 weeks. The diarrhoea improved after
3 days of GCV. Formula-feeding was rapidly increased
and the baby was discharged 37 days after admission.
Detailed investigation did not reveal any underlying
primary immunodeficiencies (normal lymphocyte sub-
sets studies, serum immunoglobulin and IgG sub-class
levels). Urinary shedding of CMV ceased during the sec-
ond year of life and neuro-developmental outcome at 2
years of age is normal.
Conclusions
In immuno-competent host, acquired CMV infection is
usually asymptomatic or may determine a mild disease.
Severe gastrointestinal disease can be observed in congeni-
tal infections [1], in children with AIDS, or in children
receiving immunosuppressive therapy post-transplantation.
CMV may also cause relapses of intestinal disease in
infants affected by inflammatory bowel diseases [3].
Additional sources are blood transfusions or contact
with genital tract secretions at delivery, whereas viral
shedding from maternal pharynx or urinary tract, during
the first months after birth, is not associated with peri-
natal transmission [4].
Finally, breast feeding is a recognized source of CMV
in the perinatal period and an important cause of
“sepsis-like” infection in very preterm infants [2].
Cheong and co-workers [5] reported 11 cases of postna-
tal CMV infection with gastrointestinal manifestations.
All infants were breast fed, 10 were delivered preterm
(range 24 to 32 wks of gestation) and one, low birth
weight newborn, was affected by Rothmund-Thomson
syndrome. Premature newborn is an immunocompro-
mised host and CMV gastrointestinal disease may result
from enteral acquisition after infected fresh milk
feeding.
In contrast, severe CMV gastrointestinal disease have
been exceptionally reported in immunocompetent
infants [6-10]. Congenital origin could not be ruled out,
therefore the pathogenesis is still unclear. Common
findings include breast feeding, the need of antiviral
therapy (4 of 5 cases) and the onset of symptoms
between 5 to 8 weeks after birth (Table 1). The incuba-
tion period of CMV infections generally ranges between
4 and 12 weeks; it is therefore likely that most of these
infants acquired infection at or soon after birth.
The infant here described had no clinical signs of the
disease at birth and laboratory testing for CMV (at
birth) were negative, therefore we could firmly exclude
congenital infection. No recognizable underlying illness
or risk factor for CMV were found. Unlike previous
reports, the infant was breast-fed for a few hours at
birth, and then formula-fed.
Horizontal CMV transmission from another child in
the household was unlikely, as the infant was an only
child.
The mother, who suffered from primary infection in
late pregnancy, was the likely source of CMV (perhaps
at birth, as a consequence of prolonged membrane rup-
ture). Perhaps intestinal surgery during the first week of
life increased disease severity. We speculate that muco-
sal injury possibly led to increased permeability with a
massive intestinal and blood CMV invasion. The
hypothesis of mucosal injury is supported by the obser-
vation of CMV colitis in immunocompetent children
with inflammatory bowel disease [3] or cow’sm i l k
allergy [8]. Further, the disease could have been wor-
sened by the lack of breast milk and maternal protective
factors (namely IgA antibodies).
Biopsies and P.C.R. assays confirmed severe bone mar-
row and intestinal CMV involvement, which promptly
recovered after antiviral therapy.
This study has some limitations. Indeed, we could not
demonstrate a molecular identity between the CMV-iso-
late of the infant and the maternal virus. Therefore the
source of CMV remains speculative, though a transmis-
sion from the maternal source it is likely.
Further, no amniocentesis was performed and some
information on maternal infection (DNAemia, viral shed-
ding in urine or saliva) was lacking. The characterization
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Clinical findings Diagnosis Mode of transmission Antiviral
therapy
Jonkhoff-Slok (8) 5 weeks Yes° Bloody diarrhoea Rectal bleeding Inclusion bodies at intestinal biopsy Perinatal ? Cow’s milk allergy
?
No
Fox (7) 5 weeks Yes Fever, Lymphoadenopathy Intractable diarrhoea Occult
blood in stools
Inclusion bodies at duodenum biopsy Congenital ? Perinatal ? i.v. GCV for 5
weeks
Quiros-Tejeira (9) 2 months Yes Fever, watery diarrhoea Severe colonic inflammatory changes,
inclusion bodies
Perinatal ? i.v. GCV for 2
weeks
Rongkavilit (10) 8 weeks Yes Profuse watery diarrhoea Inclusion bodies in duodenum and
sigmoid colon
Perinatal ? Postnatal (breast-
feeding ?)
i.v. GCV for 4
weeks
Buonuomo (1) 8 weeks Yes Fever Anaemia Melena § Positive PCR at duodenum biopsy Perinatal ? Oral VGCV for 5
weeks
GCV = Ganciclovir; VGCV = Valganciclovir; PCR = polymerase chain reaction; i.v. = intravenous
° The infant was breast fed for 4 weeks, then he was formula fed























































































4of maternal primary infection during pregnancy was
therefore incomplete.
Nevertheless, this case report contribute to understand
CMV end-organ-disease and related symptomatic infec-
tion of term infants during the first months of life. It
shows that severe disease may be acquired after birth,
even in immunocompetent, formula-fed, full-term infant.
Intractable diarrhoea may need ganciclovir therapy.
Abbreviations
CMV: cytomegalovirus; P.C.R.: polymerase chain reaction; GCV: ganciclovir;
VGCV: Valganciclovir.
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